OncoImmunology (Jan 2020)

Overproduction of IL-2 by Cbl-b deficient CD4+ T cells provides resistance against regulatory T cells

  • SeongJun Han,
  • Douglas C. Chung,
  • Michael St. Paul,
  • Zhe Qi Liu,
  • Carlos Garcia-Batres,
  • Alisha R. Elford,
  • Charles W. Tran,
  • Laurence Chapatte,
  • Pamela S. Ohashi

DOI
https://doi.org/10.1080/2162402X.2020.1737368
Journal volume & issue
Vol. 9, no. 1

Abstract

Read online

Regulatory T cells are integral to the regulation of autoimmune and anti-tumor immune responses. However, several studies have suggested that changes in T cell signaling networks can result in T cells that are resistant to the suppressive effects of regulatory T cells. Here, we investigated the role of Cbl-b, an E3 ubiquitin ligase, in establishing resistance to Treg-mediated suppression. We found that the absence of Cbl-b, a negative regulator of multiple TCR signaling pathways, rendered T cells impartial to Treg suppression by regulating cytokine networks leading to improved anti-tumor immunity despite the presence of Treg cells in the tumor. Specifically, Cbl-b KO CD4+FoxP3− T cells hyper-produced IL-2 and together with IL-2 Rα upregulation served as an essential mechanism to escape suppression by Treg cells. Furthermore, we report that IL-2 serves as the central molecule required for cytokine-induced Treg resistance. Collectively our data emphasize the role of IL-2 as a key mechanism that renders CD4+ T cells resistant to the inhibitory effects of Treg cells.

Keywords